Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing act.
Tefferi
A
A
D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D055728:Primary Myelofibrosis / Q000188:drug therapy* / Q000628:therapy*; D011379:Prognosis; D013156:Splenectomy; D015996:Survival Rate; D014184:Transplantation, Homologous